» Articles » PMID: 25980561

Clinical and Economic Burden of Community-acquired Pneumonia in the Veterans Health Administration, 2011: a Retrospective Cohort Study

Overview
Journal Infection
Date 2015 May 19
PMID 25980561
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The burden of community-acquired pneumonia (CAP) is not well described in the US Veterans Health Administration (VHA).

Methods: CAP was defined as having a pneumonia diagnosis with evidence of chest X-ray, and no evidence of prior (90 days) hospitalization/long-term care. We calculated incidence rates of adult CAP occurring in inpatient or outpatient VHA settings in 2011. We also estimated the proportion of VHA CAP patients who were hospitalized, were readmitted within 30 days of hospital discharge, and died (any cause) in the year following diagnosis. Incremental costs during the 90 days following a CAP diagnosis were estimated from the perspective of the VHA.

Results: In 2011, 34,101 Veterans developed CAP (35,380 episodes) over 7,739,757 VHA person-years. Median age of CAP patients was 65 years (95 % male). CAP incidence rates were higher for those aged ≥50 years. A majority of Veterans aged 50-64 (53 %) and ≥65 (66 %) years had ≥1 chronic medical (moderate risk) or immunocompromising (high risk) condition. Compared to those at low-risk (healthy), moderate- and high-risk Veterans were >3 and >6 times more likely to develop CAP, respectively. The percentage of CAP patients who were hospitalized was 45 %, ranging from 12 % (age 18-49, low risk) to 57 % (age ≥65, high risk). One-year all-cause mortality rates ranged from 1 % (age 18-49, low risk) to 36 % (age ≥65, high risk). Annual VHA medical expenditure related to CAP was estimated to be $750 million (M) ($415M for those aged ≥65 years).

Conclusion: A focus on CAP prevention among older Veterans and those with comorbid or immunocompromising conditions is important.

Citing Articles

Disease burden and high-risk populations for complications in patients with acute respiratory infections: a scoping review.

Cui C, Timbrook T, Polacek C, Heins Z, Rosenthal N Front Med (Lausanne). 2024; 11:1325236.

PMID: 38818396 PMC: 11138209. DOI: 10.3389/fmed.2024.1325236.


A Sequent of Gram-Negative Co-Infectome-Induced Acute Respiratory Distress Syndrome Are Potentially Subtle Aggravators Associated to the SARS-CoV-2 Evolution of Virulence.

Said K, Alsolami A, Alshammari K, Alshammari F, Alhallabi S, Alafnan S Diagnostics (Basel). 2024; 14(1).

PMID: 38201429 PMC: 10802668. DOI: 10.3390/diagnostics14010120.


Molecular and Source-Specific Profiling of Hospital Reveal Dominance of Skin Infection and Age-Specific Selections in Pediatrics and Geriatrics.

Said K, AlGhasab N, Alharbi M, Alsolami A, Saleem M, Alhallabi S Microorganisms. 2023; 11(1).

PMID: 36677441 PMC: 9862673. DOI: 10.3390/microorganisms11010149.


Clinical and economic burden of pneumococcal disease among individuals aged 16 years and older in Germany.

Deb A, Podmore B, Barnett R, Beier D, Galetzka W, Qizilbash N Epidemiol Infect. 2022; 150:e204.

PMID: 36345842 PMC: 9987016. DOI: 10.1017/S0950268822001182.


Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis.

Kato H, Hagihara M, Asai N, Hirai J, Yamagishi Y, Iwamoto T Antibiotics (Basel). 2022; 11(10).

PMID: 36289949 PMC: 9598877. DOI: 10.3390/antibiotics11101291.


References
1.
File Jr T, Marrie T . Burden of community-acquired pneumonia in North American adults. Postgrad Med. 2010; 122(2):130-41. DOI: 10.3810/pgm.2010.03.2130. View

2.
Niederman M . How do we optimize outcomes for patients with severe community-acquired pneumonia?. Intensive Care Med. 2002; 28(8):1003-5. DOI: 10.1007/s00134-002-1324-4. View

3.
Broulette J, Yu H, Pyenson B, Iwasaki K, Sato R . The incidence rate and economic burden of community-acquired pneumonia in a working-age population. Am Health Drug Benefits. 2014; 6(8):494-503. PMC: 4031734. View

4.
Hynes D, Koelling K, Stroupe K, Arnold N, Mallin K, Sohn M . Veterans' access to and use of Medicare and Veterans Affairs health care. Med Care. 2007; 45(3):214-23. DOI: 10.1097/01.mlr.0000244657.90074.b7. View

5.
Isea-Pena M, Sanz-Moreno J, Esteban J, Fernandez-Roblas R, Fernandez-Guerrero M . Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae. Infection. 2013; 41(5):935-9. PMC: 7102337. DOI: 10.1007/s15010-013-0481-4. View